Literature DB >> 11916921

Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity.

Ranjana Sinha1, Sylvie Dufour, Kitt Falk Petersen, Vincent LeBon, Staffan Enoksson, Yong-Zhan Ma, Mary Savoye, Douglas L Rothman, Gerald I Shulman, Sonia Caprio.   

Abstract

The metabolism and composition of skeletal muscle tissue is of special interest because it is a primary site of insulin action and plays a key role in the pathogenesis of insulin resistance. Intramyocellular (IMCL) triglyceride stores are an accessible form of energy that may decrease skeletal muscle glucose utilization, thereby contributing to impaired glucose metabolism. Because of the invasive nature of muscle biopsies, there is limited, if any, information about intramuscular lipid stores in children. The development of (1)H nuclear magnetic resonance (NMR) spectroscopy provides a unique noninvasive alternative method that differentiates intracellular fat from intercellular fat in muscle tissue. The present study was performed to determine whether IMCL and extramyocellular (EMCL) lipid contents are increased early in the development of juvenile obesity and to explore the relationships between IMCL and EMCL to in vivo insulin sensitivity, independently of total body fat and central adiposity in obese and nonobese adolescents. Eight nonobese (BMI 21 kg/m(2), age 11-16 years) and 14 obese (BMI 35 +/- 1.5 kg/m(2), age 11-15 years) adolescents underwent 1) (1)H-NMR spectroscopy to noninvasively quantify IMCL and EMCL triglyceride content of the soleus muscle, 2) a 2-h euglycemic-hyperinsulinemic clamp (40 mU.m(-2).min(-1)) to assess insulin sensitivity, 3) a dual-energy X-ray absorptiometry scan to measure total percent body fat, and 4) magnetic resonance imaging to measure abdominal fat distribution. Both the IMCL and EMCL content of the soleus muscle were significantly greater in the obese adolescents than in the lean control subjects. A strong inverse correlation was found between IMCL and insulin sensitivity, which persisted and became even stronger after controlling for percent total body fat and abdominal subcutaneous fat mass (partial correlation r = -0.73, P < 0.01) but not when adjusting for visceral fat (r = - 0.54, P < 0.08). In obese adolescents, increase in total body fat and central adiposity were accompanied by higher IMCL and EMCL lipid stores. The striking relationships between both IMCL and EMCL with insulin sensitivity in childhood suggest that these findings are not a consequence of aging but occur early in the natural course of obesity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916921     DOI: 10.2337/diabetes.51.4.1022

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  150 in total

Review 1.  The role of lipid droplets in metabolic disease in rodents and humans.

Authors:  Andrew S Greenberg; Rosalind A Coleman; Fredric B Kraemer; James L McManaman; Martin S Obin; Vishwajeet Puri; Qing-Wu Yan; Hideaki Miyoshi; Douglas G Mashek
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects.

Authors:  E E Blaak; S L Schiffelers; W H Saris; M Mensink; M E Kooi
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

Review 3.  The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans.

Authors:  Martin Krssak; Michael Roden
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 4.  Quantitative computed tomography and computed tomography in children.

Authors:  Babette S Zemel
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

5.  Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children.

Authors:  D E Larson-Meyer; B R Newcomer; E Ravussin; J Volaufova; B Bennett; S Chalew; W T Cefalu; M Sothern
Journal:  Diabetologia       Date:  2010-12-23       Impact factor: 10.122

Review 6.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

7.  Intramyocellular lipids: maker vs. marker of insulin resistance.

Authors:  Zengkui Guo
Journal:  Med Hypotheses       Date:  2007-09-04       Impact factor: 1.538

8.  Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.

Authors:  Ram Weiss; Sylvie Dufour; Sara E Taksali; William V Tamborlane; Kitt F Petersen; Riccardo C Bonadonna; Linda Boselli; Gina Barbetta; Karin Allen; Francis Rife; Mary Savoye; James Dziura; Robert Sherwin; Gerald I Shulman; Sonia Caprio
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

9.  Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.

Authors:  M Skovbro; M Baranowski; C Skov-Jensen; A Flint; F Dela; J Gorski; J W Helge
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

Review 10.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.